BERGER FRANKLIN M

SEC source: 0001209191-21-002944 · doc4.xml · nonDerivative · entry 3

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 868,471

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-002944 · doc4.xml · nonDerivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 866,287

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-21-002944 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 859,753

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 7

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,474 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 6

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 60,540 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 5

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 131,578 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 4

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 132,014 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-030331 · doc4.xml · derivative · entry 3

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 400,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.exercise_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

F1 · derivative.expiration_date: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-030331 · doc4.xml · nonDerivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 820,019

SEC source: 0000899243-20-030331 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 778,353

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The preferred stock was convertible at any time, at the holder's election and had no expiration date. Each share of preferred stock was automatically converted into one share of common stock upon the closing of the Issuer's initial public offering of its common stock.

SEC source: 0000899243-20-029959 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,000

Underlying: Common Stock · 80,000 shares

Expires 2030-10-28

F1 · derivative.exercise_date: The option vests and becomes exercisable in 36 equal monthly installments following October 29, 2020.

SEC source: 0001209191-20-039861 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,400

Underlying: Common Stock · 17,400 shares

Expires 2030-06-29

F1 · derivative.exercise_date: These securities shall vest and become exercisable in equal quarterly installments starting on September 29, 2020 until the option is fully vested and exercisable on June 29, 2021, subject to the Reporting Person continuing to provide services to the Issuer.

SEC source: 0001209191-20-039110 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,896

Underlying: Common Stock · 8,896 shares

Expires 2030-06-23

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option shall vest on 6/24/2021, subject to Reporting Person continuing to provide service through such date.

SEC source: 0001209191-20-036045 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 784,003

F1 · price: Shares were purchased in a public offering of the Issuer at a public offering price of $5.50.

SEC source: 0001209191-20-036669 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,000

Underlying: Class A Common Stock · 12,000 shares

Expires 2030-06-09

F1 · derivative.exercise_date: The option vests upon the earlier of the one-year anniversary of the date of grant or the day prior to the next Annual Meeting of Stockholders occurring after the grant date, subject to the non-employee director's continuous service on each applicable vesting date. All unvested options will vest in full immediately prior to a change in control (as defined in the Company's 2019 Equity Incentive Plan), subject to the non-employee director's continuous service as of immediately prior to the closing of such change in control.

SEC source: 0001209191-20-029825 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-05-13

F1 · derivative.exercise_date: This option will vest in its entirety on the earlier to occur of (i) May 14, 2021 or (ii) the day before the 2021 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.

SEC source: 0001209191-20-007050 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 684,003

F1 · price: Shares were purchased in a public offering of the Issuer at a public offering price of $2.60.

SEC source: 0001209191-19-059155 · doc4.xml · nonDerivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.97 to $4.03, inclusive.

SEC source: 0001209191-19-059155 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,890

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.88 to $3.96, inclusive. The reporting person undertakes to provide to Five Prime Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.

SEC source: 0001209191-19-052618 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires 2029-10-03

F1 · derivative.exercise_date: The shares vest in a series of twelve (12) successive equal monthly installments measured from October 3, 2019.

SEC source: 0001209191-19-039703 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,300

Underlying: Common Stock · 15,300 shares

Expires 2029-06-27

F1 · derivative.exercise_date: These securities shall vest and become exercisable in equal quarterly installments starting on June 27, 2019 until the option is fully vested and exercisable on June 27, 2020, subject to continued service.

SEC source: 0001209191-19-039246 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,896

Underlying: Common Stock · 8,896 shares

Expires 2029-06-24

F1 · derivative.exercise_date: One-hundred percent (100%) of the shares subject to the option shall vest on 6/25/2020, subject to Reporting Person continuing to provide service through such date.

SEC source: 0001209191-19-038782 · doc4.xml · derivative · entry 4

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 13,164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.exercise_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.expiration_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

SEC source: 0001209191-19-038782 · doc4.xml · derivative · entry 3

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 26,115 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.exercise_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.expiration_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

SEC source: 0001209191-19-038782 · doc4.xml · derivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 36,036 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.exercise_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

F1 · derivative.expiration_date: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

SEC source: 0001209191-19-038782 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The preferred stock automatically converted into Class A common stock on a 1-to-1 basis immediately upon closing of the initial public offering of the Issuer and has no expiration date.

SEC source: 0001209191-19-036506 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2029-06-09

F1 · derivative.exercise_date: This option will vest in its entirety on the earlier to occur of (i) June 10, 2020 or (ii) the day before the 2020 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.

SEC source: 0001209191-19-033641 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2029-05-28

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 monthly installments following the date of grant.

SEC source: 0001209191-19-023691 · doc4.xml · derivative · entry 4

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F3 · derivative.expiration_date: Not Applicable.

SEC source: 0001209191-19-023691 · doc4.xml · derivative · entry 3

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F3 · derivative.expiration_date: Not Applicable.

SEC source: 0001209191-19-023691 · doc4.xml · derivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires not disclosed

F2 · price: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F2 · derivative.exercise_date: Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each of these stock options accelerated and became fully vested and converted into the right to receive cash in the amount equal to the product of (i) the total number of Shares subject to the such stock option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of (x) the Merger Consideration over (y) the exercise price payable per share.

F3 · derivative.expiration_date: Not Applicable.

SEC source: 0001209191-19-023691 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated February 20, 2019, by and among the Immune Design Corp. (the "Issuer"), Merck Sharp & Dohme Corp., a New Jersey corporation ("Parent") and Cascade Merger Sub Inc., a Delaware corporation ("Purchaser"), on April 2, 2019, Purchaser merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent. In connection with the Merger, the Issuer's common stock were cancelled and converted into the right to receive $5.85 in cash per share, less any required withholding, subject to the terms and conditions of the Merger Agreement ("Merger Consideration").

SEC source: 0001209191-19-002659 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2029-01-03

F1 · derivative.exercise_date: All shares underlying the option will vest on January 3, 2020.

SEC source: 0001209191-18-056298 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By: FMB Research

Disclosed balance after: 40,000

SEC source: 0001209191-18-039668 · doc4.xml · derivative · entry 5

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 197,076 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001209191-18-039668 · doc4.xml · derivative · entry 4

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 262,907 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001209191-18-039668 · doc4.xml · nonDerivative · entry 3

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 563,157

SEC source: 0001209191-18-039668 · doc4.xml · nonDerivative · entry 2

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 513,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001209191-18-039668 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 316,081

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.

SEC source: 0001209191-18-039405 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-06-20

F1 · derivative.exercise_date: The stock option vests and becomes exercisable in 12 monthly installments following the date of grant.

SEC source: 0001209191-18-038526 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,300

Underlying: Common Stock · 15,300 shares

Expires 2028-06-15

F1 · derivative.exercise_date: These securities shall vest and become exercisable in equal quarterly installments starting on June 15, 2018 until the option is fully vested and exercisable on June 15, 2019, subject to continued service.

SEC source: 0001209191-18-030035 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-05-09

F1 · derivative.exercise_date: This option will vest in its entirety on the earlier to occur of (i) May 10, 2019 or (ii) the day before the 2019 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.

SEC source: 0001209191-18-002818 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2028-01-04

F1 · derivative.exercise_date: All shares underlying the option will vest on January 4, 2019.

SEC source: 0001209191-17-066244 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,162

SEC source: 0001209191-17-058672 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

F1 · price: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $4.55 to $4.60 on October 30, 2017. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001209191-17-058081 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

F1 · price: The price reported on Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.20 to $4.30 on October 25, 2017. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-17-047889 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,663

Underlying: Common Stock · 63,663 shares

Expires 2027-08-03

F1 · derivative.exercise_date: These securities shall vest and become exercisable in equal quarterly installments starting on August 3, 2017 until the option is fully vested and exercisable on August 3, 2018, subject to continued service.

SEC source: 0001209191-17-031910 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2027-05-09

F1 · derivative.exercise_date: This option will vest in its entirety on the earlier to occur of (i) May 10, 2018 or (ii) the day before the 2018 annual meeting of stockholders of Five Prime Therapeutics, Inc. (the "Company"), subject to the reporting person's continued service to the Company through such vest date.

SEC source: 0001209191-17-027907 · doc4.xml · nonDerivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,335

F1 · kind: Represents the conversion of an outstanding convertible promissory note in the principal amount of $250,000, plus $3,356.16 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share.

SEC source: 0001209191-17-026756 · doc4.xml · derivative · entry 1

BERGER FRANKLIN M · CIK 0001273885 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,246

Underlying: Common Stock · 7,246 shares

Expires 2027-04-11

F1 · derivative.exercise_date: 1/4th of the shares vest one year after 4/1/2017; the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of 4/1/2017.